Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins - Wikidata - wikimedia - TriplyDB

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

http://www.wikidata.org/entity/Q26799906

about

Headache Attributed to Craniocervical Dystonia - A Little Known Headache.Injection of high dose botulinum-toxin A leads to impaired skeletal muscle function and damage of the fibrilar and non-fibrilar structures.Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine.Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.

P2860

Q39026792-BED05E37-A8A3-455E-AABC-34BA4C8829A1 Q45334679-D8CE038F-0A0D-4238-B622-2ADB5476513E Q47410678-2FB39534-A629-4345-9853-31277EDC5ABB Q48505652-AA156205-1137-4AD7-B67D-415CFB1CA82F

P2860

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

http://www.wikidata.org/entity/Q26799906

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

@ast

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

@en

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

@nl

type

label

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

@ast

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

@en

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

@nl

prefLabel

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

@ast

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

@en

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

@nl

P1433

Q26799906-C1C6CCE4-F806-4A86-8818-383EA0466832

P1476

Q26799906-F28BDBAB-76C9-489D-88B0-002FF2E58DD6

P2093

Q26799906-31563E07-7B28-4A31-BD61-B6B1598621D9

Q26799906-CFE9939F-3F31-4934-8D62-8E213284551C

Q26799906-D1C93420-4963-40D4-BB3D-AF62FB29BCDC

P275

Q26799906-4D1C3419-5764-4E6B-B86E-237498A808DD

P2860

Q26799906-04825F59-55E5-47DF-A5C0-23FFEFF565A5

Q26799906-05C5CCFC-6CE6-46C2-BCBF-DDF6D3453064

Q26799906-168D7D6D-2287-4952-B252-635C45E83627

Q26799906-1A690381-0DAA-4642-BA13-BB8CC5537BAC

Q26799906-2EA48F46-188B-4AF4-88E8-DD1A7912ECF5

Q26799906-4CB5400B-77BD-4D1E-A5AF-649672E2B923

Q26799906-5165D22A-AFBB-4183-87AC-91083E57065D

Q26799906-53C299D8-A736-4D39-8871-091EFA28BA32

Q26799906-5C88F328-D7F8-495A-82CD-29652CCD875C

Q26799906-5FBDD3F7-FC31-4E6F-A4CC-20AD2CC043D8

P304

Q26799906-A7181315-FCE9-42CF-AEBD-AAA495DB0934

P31

Q26799906-20E63F0A-E794-45AF-893F-C3FF5C855A41

Q26799906-D0576A9F-ACA6-42F5-AF14-E9A31B7FB7CC

P356

Q26799906-0B88E0F4-1EB4-4F4D-B1A9-BB050E933DDD

P407

Q26799906-6DB5C644-B031-430E-97D6-3B5C1471B01F

P433

Q26799906-383F5B37-6F8B-4BE3-9005-3DB7E1B55814

P478

Q26799906-136A10F3-EFBA-4E1A-99B5-8AACB7471CE9

P5008

Q26799906-FDEEB0CF-AACB-448D-970F-2095937148F9

P577

Q26799906-472128C5-0FA7-4162-85AA-623C7D8F1E95

Q26799906-C35F17BA-B2F4-41F2-9DD1-C483C7714FC7

P5875

Q26799906-65058E8E-C088-4E12-82A8-33E070F152D3

P698

Q26799906-F5FA281C-CDCC-41C7-8736-A437BD38EEBD

P921

Q26799906-1BFCF1C5-B2B2-4CCE-8F18-CF7F9E537AD5

Q26799906-5ADD9A4E-1723-48CA-9573-CBAC25A44967

Q26799906-CE6F9B29-7901-4575-8B68-A6736D1F3C25

P932

Q26799906-E09C6C19-5BC6-44B8-8085-892F32AB6FF1

P356

P1433

P1476

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

@en

P2093

Bahman Jabbari

http://www.w3.org/2001/XMLSchema#string

Christopher H Gottschalk

http://www.w3.org/2001/XMLSchema#string

Sara M Schaefer

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

The International Classification of Headache Disorders: 2nd edition

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.

Procedures for administering botulinum toxin type A for migraine and tension-type headache.

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.

Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: therapeutic implications for migraine and other pains.

On the temporal relationship between throbbing migraine pain and arterial pulse.

Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.

The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Evidence for antinociceptive activity of botulinum toxin type A in pain management.

P304

2615-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/TOXINS7072615

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281805951

http://www.w3.org/2001/XMLSchema#string

P698

26184313

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

bacterial protein

P932

4516932

http://www.w3.org/2001/XMLSchema#string